Skip to content

Anemia

Margaret Wheless


Presentation

  • Symptoms:
    • Fatigue/malaise, dyspnea on exertion, angina (if history of CAD)
  • Signs:
    • Pallor, tachycardia, orthostatic hypotension, purpura, glossitis, koilonychia (in IDA)
    • Jaundice (if hemolysis)
    • Splenomegaly: suggests extramedullary hematopoiesis or sequestration
    • Neurologic symptoms: suggests B12 deficiency

Evaluation

  • CBC w/diff, reticulocyte count, peripheral blood smear, Iron studies (TIBC, Ferritin)
  • RI > 2%: blood loss vs hemolysis; see below
    • Hemolysis labs: Bilirubin, LDH, haptoglobin
  • RI < 2%: hypoproliferative stratify based on RBC size
    • Microcytic (<80) vs. Normocytic (80-100) vs. Macrocytic (>100)

Reticulocyte Index >2%

Background

  • Etiology: Consumption vs Blood loss
  • Loss: acute bleed vs iatrogenic from labs
  • Hemolysis: Microangiopathic hemolytic anemia (MAHA), autoimmune hemolytic anemia (AIHA), intrinsic RBC defects

Evaluation

  • LDH, ↑indirect bilirubin, ↓haptoglobin, PT/PTT
  • Peripheral blood smear: evaluated for schistocytes, bite cells, spur cells, spherocytes, etc.
  • Direct antiglobulin test (DAT) to evaluate for autoimmune hemolytic anemia

Extrinsic RBC causes

  • If schistocytes ± thrombocytopenia = MAHA: TTP, DIC, HUS, HELLP, mechanical valves, malignant HTN, cocaine, scleroderma renal crisis
  • If DAT positive = AIHA

Intrinsic RBC causes

  • Sickle cell disease: chronic hemolysis + splenic sequestration crisis where RI is↑ vs aplastic crisis where RI is↓ (see sickle cell section)
  • Hereditary spherocytosis
  • Hereditary elliptocytosis
  • PNH
  • G6PD: bite cells, Heinz bodies
    • Usually precipitated by drugs: nitrofurantoin, dapsone, sulfonamides, rasburicase, primaquine

Management

  • MAHA
  • DIC: sepsis, malignancy, pregnancy
    • Treat underlying cause
    • If active bleeding: FFP, cryoprecipitate (to keep fibrinogen >100) and platelets
  • TTP: Order ADAMTS13 (prior to plasma transfusion or exchange)
    • If concern for TTP you should immediately consult Heme and Nephrology
  • HUS: + shiga toxin, AKI, diarrhea
  • AIHA:
    • Cold (rare): IgM binds at temp <37
      • Caused by lymphoproliferative disorder (Waldenström Macroglobulinemia), mycoplasma, EBV, HIV
      • Consult heme. Treat underlying. Consider rituximab (steroids ineffective)
    • Warm: IgG
      • Idiopathic or associated with lymphoma, SLE, drugs, babesiosis, HIV
      • Can use steroids, IVIG, rituximab

Reticulocyte Index <2% (RBC Size Framework)

Normocytic Anemia: MCV 80-100

  • Etiologies
    • Anemia of inflammation: (may also be microcytic)
    • Anemia of CKD: low Erythropoietin (EPO) levels
    • Endocrine disease (hypothyroidism, adrenal insufficiency): ↓metabolic demand/O2 requirement
    • Mixed macrocytic/microcytic disease may have a normal MCV: look for ↑RDW
    • Pure red cell aplasia: associated with destructive Ab (CLL, thymoma, parvovirus, autoimmune)
    • Paroxysmal nocturnal hemoglobinuria (PNH)
    • Bone marrow failure or infiltration (typically will see pancytopenia)
    • Bone marrow biopsy may be indicated if no identifiable cause or anemia is associated with other cytopenia’s

Microcytic anemia: MCV <80 (mnemonic: SALTI)

  • Sideroblastic, Anemia of chronic disease, Lead poisoning, Thalassemia and Iron-deficiency
Disease Etiology Evaluation Considerations
Sideroblastic

MDS

Idiopathic

EtOH, Lead, Isoniazid

Cu deficiency

Social hx, TB, consider Lead level

Fe: ↑↑

Ferritin: ↑ to nL

TIBC: nL

Smear: basophilic stippling

BMBx: ringed sideroblasts

In clinical practice this is usually acquired; either due to alcohol (can resolved with cessation) or primary bone marrow disorder (e.g. MDS-RARS)
Anemia of Inflammation (formerly chronic disease) Chronic inflammation, malignancy, HIV, autoimmune dz, heart failure, etc.

Fe/TIBC >18%

Fe: ↓↓

Ferritin: ↑↑

TIBC: ↓↓

Treat underlying disease

Replete Fe if ferritin <100 or TIBC <20%

EPO if Hgb <10 and serum EPO <10

Thalassemia

↓ synthesis of α or β chains leads to ↓ erythropoiesis and ↑ hemolysis

Family Hx of anemia

Mentzer’s index: MCV/RBC <13 = thalassemia

Normal Fe studies; can mimic microcytic anemia and Fe overload from transfusions

Diagnosis: Hb electrophoresis (α will be normal)

α-thal more common in Asian/African descent

β thal common in Mediterranean descent

Tx: transfusions, folate, Fe chelator depending on severity

Iron (Fe) deficiency

Chronic bleeding: colon cancer, heavy menstrual periods, cirrhosis (portal gastropathy)

Supply: malnutrition, Crohn’s dz, Celiac dz, subtotal gastrectomy

Demand: pregnancy

Fe/TIBC <18%

Fe:↓↓ TIBC:↑ nl to ↑

Ferritin: < 100

Mentzer’s index: >13

Consider celiac testing based on clinical suspicion

Investigate for GIB or source of blood loss

Oral Fe: 6wks to correct anemia, 6mo to replete stores; dose every other day (↑ absorption w/ ↓ GI side effects); add Vit C for ↑ absorption

If can’t tolerate PO consider IV Fe (Avoid when bacteremic)

HFrEF: IV Fe if ferritin <100 OR 100-300 w/ Fe sat <20%

Macrocytic Anemia: MCV >100

  • Non-megaloblastic

    • ETOH, liver disease, hypothyroidism, MDS
    • Medications that impair DNA synthesis: zidovudine, 5-FU, hydroxyurea, ara-C, AZT, MTX
  • Megaloblastic

    • B12 deficiency
      • Presentation: neurologic changes (subacute combined degeneration), paresthesia, ataxia, dementia (reversible with early treatment)
      • Etiology: malnutrition (alcoholics, vegan), pernicious anemia, gastrectomy, Crohn’s disease, chronic pancreatitis, celiac disease
      • Diagnosis: ↓B12, ↑MMA, ↑homocysteine
      • Treatment: either monthly IM or sublingual B12 (oral not absorbed if no IF)
    • Folate deficiency
      • Etiology: malnutrition, decreased absorption (e.g. Celiac disease), impaired metabolism (MTX, TMP), ↑requirement (hemolysis, malignancy, dialysis)
      • Diagnosis: ↓folate, ↑homocysteine, MMA will be normal
      • Treatment: PO folate 1-4 mg daily

Last update: 2022-06-25 02:34:38